Saturday, March 28, 2020

Colleges Get Proactive in Addressing Depression on Campus

From The New York Times: The number of college students with mental health concerns is rapidly increasing, straining many universities' mental health and counseling centers. Colleges...

Feds Close ‘Evidence Based’ National Registry

From Education Week: The Substance Use and Mental Health Services Administration has put a halt on the National Registry of Evidence-Based Programs and Practices, a...

New York Times Issues Correction on RAISE Study Report

Last Tuesday, The New York Times and several other outlets (including Mad In America) reported on the highly-touted results of a study on psychosocial treatment for patients diagnosed with schizophrenia. Now, claims made about the study, which the ‘Times called “the most rigorous trial to date,” are coming under increased scrutiny.

Anxiety and the Severity of Mania

Researchers from Spain, noting that "anxiety has scarcely been studied in acute mania," analyzed data from 242 patients admitted for a diagnosis of acute...

Depressed People Surf Differently

In a study to be published in a forthcoming IEEE Technology and Society researchers at  Missouri University recruited 216 undergraduates, finding that the 30% who...

Maternal Skin-to Skin Contact Affects Long-Term Development

Israeli researchers find that maternal skin-to-skin contact with pre-term infants are related to "dynamic cascades of child physiological regulation and parental provisions in shaping...

Vermont Moves to Community Care After Hurricane Destroys State Hospital

Vermont Governor Peter Shumlin "is going to use this tragedy of losing our State Hospital during (hurricane) Irene as an opportunity to deliver the...

“Janssen Accused of Withholding Data on Risperdal Side Effect in Autism”

MedPageToday reports that Janssen Pharmaceuticals omitted data from a 2003 study that connected Risperdal with serious side effects. Janssen was previously sued by the FDA for marketing Risperdal for off-label uses and settled for $2.2 billion in 2013. Earlier this year, a man with autism was awarded $2.5 million after growing breasts while on Risperdal. According to MedPage, documents from this latest case reveal missing data tables from a 2003 study “designed to ferret out potential adverse effects of long-term risperidone use.” The missing tables were related to elevated prolactin levels and side effects, including gynecomastia in men.

Cognitive Enhancement With Yoga

From Psychiatric Times: A recent study suggests that Kundalini yoga may be at least as effective as memory training in improving cognitive resilience in older adults with...

“What’s it Really Like to Take Antidepressants?”

Britain's offers videotaped interviews with 36 people in their homes, talking about their decision to take antidepressants and the impact of that decision...

“Helping Others Dampens the Effects of Everyday Stress”

"The holiday season can be a very stressful time, so think about giving directions, asking someone if they need help, or holding that elevator...

Therapy Gets More Effective Over Time While Antidepressants Decrease in Effectiveness

New review of long-term depression data finds psychotherapy more effective over time whereas antidepressants decrease in effectiveness.

Brand Fascism

The norm in science is that there is free access to the data underpinning experiments. If free access is denied; it’s not science. In the case of branded pharmaceuticals, we do not even know what trials have been done. What is put in the public domain is not data. The selected highlights of a football game and the comments of the pundits afterwards don't change the score. The selected highlights of pharma studies and the comments of pundits routinely change the score.

Are DNA Changes the Link Between Poverty and Mental Illness?

Researchers at Duke University who studied 183 adolescents for three years found that increased depression associated with poverty may be mediated by epigenetic changes in DNA. The...

Discontinuing Psychotropics Reduces Falls in Elderly

Australian researchers look at the literature on the effect of psychotropics on falls in the elderly; largest effect of any randomized trial was achieved...

The Impact of Mindfulness on Mental Health Stigma Resistance

A new study examines the association of mindfulness and stigma resistance among individuals with a psychiatric diagnosis.

Experts Demand Shutdown of ECT Study

A group of mental health experts are calling for Manchester University and the UK National Institute for Health Research to immediately suspend and investigate...

Study Challenges Assumption that Schizophrenia Impairs Cognitive Ability

Secondary factors may impair performance on cognitive tasks, making it difficult for individuals diagnosed with schizophrenia to perform to the best of their ability.

“Controversial Paxil Paper Still Under Fire 13 Years Later”

From Wednesday's Brown Daily Herald: "Two weeks ago, Edmund Levin and George Stewart, members of the American Academy of Child and Adolescent Psychiatry, sent...

Loneliness as Lethal: Researchers Name Social Isolation a ‘Public Health Threat’

Researchers present loneliness as a health threat facing a growing number of Americans.

Anticholinergic Medications Linked to Dementia Similar to Early Alzheimer’s

A new study, published in the Journal of Clinical Psychiatry, investigates the effects of anticholinergic medications, such as antidepressants and antipsychotics, on cognition in older adults diagnosed with schizophrenia.

Illinois Rep. Calls for Task Force to Investigate “False Epidemics” and Psychotropic Drugs

Rep. Mary Flowers (D-Chicago) has introduced a resolution to the Illinois House of Representatives calling for a 'Task Force on Mental Diagnosis and Illinois...

Regulatory Capture

Around the world, drug regulatory agencies spend billions of dollars engaged in activities which purport to ensure the safety, efficacy and quality of legal drugs. If the goal of regulation is to protect public health and safety, there can be no argument that it has failed. Safe drugs are not associated with annual rises in mortality and morbidity, effective drugs are not associated with increased prevalence of the conditions they are designed to treat and with greater chronicity of those conditions, quality drugs are not discovered to be contaminated with solvents months after their manufacture and release to the market. Effective regulation does not see companies repeatedly breaching standards and shrugging off sanctions.

No Long-Term Efficacy For A.D.D. Medication

L. Alan Sroufe, emeritus professor of psychology at the University of Minnesota, writes in the New York Times Sunday Review that there is no...

“On Human Experiments”

-The Conversation has run a seven-article series discussing the history, politics and philosophical underpinnings of ethically questionable medical research.

Follow Us